PW Medtech Group Limited (SEHK:1358) announces a share repurchase program. Under the program, the company will repurchase up to HKD 150 million worth of its shares. The repurchase price for shares shall not be higher by 5% or more over the average closing market price for the five trading days immediately preceding each repurchase.

The Company will finance the Share Repurchase Plan from its existing available cash. The program will be valid for 12 months.